Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADM vs GSK✓SelectedUSD · GSKADM vs GSK performance historyLatest closeAs of-1.63%11/17
Stock and ETF performance explorer

ADM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.2%
GSK return
+43.9%
Excess return
-22.7%
Maximum drawdown
-54.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-2.3%+0.7%-1.2%
7D+0.2%-3.0%+3.3%+0.8%
30D-15.9%+0.4%-16.3%-16.0%
3M-14.0%-1.2%-12.8%-13.9%
6M-12.5%+0.9%-13.4%-13.0%
YTD+23.3%+4.0%+19.3%+21.1%
1Y+21.7%+7.3%+14.4%+18.7%
3Y+3.2%+57.1%-53.9%-9.4%
5Y+21.2%+43.0%-21.8%+8.3%
All+21.2%+43.9%-22.7%+8.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling